CLSA Downgrades Mead Johnson Nutrition (MJN) to Underperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/26/2024
- Stocks face worst month since September, yen swings after BoJ
- Microsoft fiscal Q3 results top estimates as AI revolution spurs cloud growth
- Alphabet stock surges 11% to record high on Q1 earnings beat, first-ever dividend
- Intel slides in afterhours trading as Q1 revenue misses, Q2 outlook falls short
- Oil prices on track to snap two-week losing streak
- Rubrik (RBRK) Prices Upsized 23.5M Share IPO at $32/sh
- Union Pacific beats profit estimates on stronger pricing, resumes share buyback
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- Hertz Global (HTZ) misses earnings expectations as fleet costs weigh
- Teladoc (TDOC) Misses Q1 EPS by 3c, offers outlook
- After-hours movers: Alphabet, Microsoft, Snap, Intel, and more
- Midday movers: Meta, IBM, Caterpillar fall; Chipotle rises
- After-hours movers: Meta, Ford, IBM, ServiceNow and more
- Midday movers: Tesla, Boeing rise; Uber, Old Dominion Freight fall
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
JPMorgan Downgrades Mead Johnson Nutrition (MJN) to Neutral
October 28, 2016 7:07 AM EDTJPMorgan downgraded Mead Johnson Nutrition (NYSE: MJN) from Overweight to Neutral with a price target of $75.00 (from $90.00).
For an analyst ratings summary and ratings history on Mead Johnson Nutrition click here. For more ratings news on Mead Johnson Nutrition click here.
Shares of Mead Johnson Nutrition closed at $74.65 yesterday.
... MoreMead Johnson (MJN) Tops Q3 EPS by 1c; Guides In-Line
October 27, 2016 7:37 AM EDTMead Johnson (NYSE: MJN) reported Q3 EPS of $0.87, $0.01 better than the analyst estimate of $0.86. Revenue for the quarter came in at $937.5 million versus the consensus estimate of $933.12 million.
GUIDANCE:
Mead Johnson sees FY2016 EPS of $3.43-$3.50, versus the consensus of... More
